4

OWNERSHIP DOCUMENT

Company: Eledon Pharmaceuticals, Inc.
Filed: December 28, 2020
Period of Report: December 22, 2020
Accession Number: 0000921895-20-003278

View Document ↗ View on SEC.gov ↗